Ensuring patient and consumer safety is one of the utmost priorities in pharmaceutical, healthcare and cosmetic product manufacture. Strict adherence to Good Manufacturing Practices (GMP) during product manufacture, storage, and shipping as well as regular, properly executed microbial limit testing ensures the lowest possible microbial burden in finished products. Proper testing, however, is necessary to confirm microbial safety. To this end, Microbial Limits Testing (MLT) is an important part of safety assessments during the production process.
MLT estimates the amount of viable aerobic microorganisms, the absence of pathogens, and also identifies the presence of particular microbial species in a product. Taken together, results from microbial limits testing determines whether a product complies with specified compendial requirements for microbial burden and user safety.
Microbial limits may be assessed at multiple stages of manufacture—from raw materials to the final product. MLT may also include consideration of the impact of time and/or storage on product safety and integrity. The ultimate testing frequency will depend on the product type and intended product usage. In the case of nonsterile pharmaceutical products, the specific approach taken to microbial limits testing considers intended use and possible user risks.
For best results, MLT should be performed by qualified personnel with experience in microbiology and related analytical methods. CPT Labs can provide expertise with microbial control testing services—including microbial enumeration and specified microbial organism analysis.
CPT performs microbial limit testing along USP <61> and <62> compendial methods, which provide directives for Microbial Enumeration Suitability and Testing for Specified Organisms, respectively. Microbial Enumeration Tests determine the total number of aerobic organisms, yeast, and mold in a product, while Tests for Specified Microorganisms identify the presence or absence of specific intolerable organisms. These chapters have been harmonized for US, European, British, and Japanese markets.
Microbiological quality acceptance criteria for non-sterile products depends on how the product is used (i.e., route of administration) and the nature of the product itself.
| Tests | US Pharmacopoeia (USP) | European Pharmacopoeia (EP) | British Pharmacopoeia (BP) | Japanese Pharmacopoeia (JP) |
| Examination of Non-Sterile products: Microbial Enumeration Test (MET) | USP<61> | EP chapter 2.6.12 | BP chapter B2 | Japanese Pharmacopoeia XV 1st Supplement |
| Examination of Non-Sterile Products: Tests for Specified Microorganisms | USP<62> | EP chapter 2.6.13 | BP chapter B1 | Japanese Pharmacopoeia XV 1st supplement |
Before Microbial Limit Testing may be performed, the method must first be validated to ensure that the tests used are able to detect microorganisms in the product itself and that product doesn’t have inherent antimicrobial properties which could encourage false negatives. If antimicrobial activity is detected in a product, neutralization agents must be added to assess microbial bioburden in subsequent tests. (If the detected antimicrobial activity cannot be neutralized, the inhibited microorganism is assumed to not be present in the product.) Suitability testing should be repeated if there is a change in the product formulation that could interfere with test outcome.
Suitability testing has three phases: Growth Promotion, Suitability of the Counting Method (Validation), and Suitability Tests for Specified Microorganisms (Validation). If the product inhibits microbial growth, the antimicrobial component(s) in the product must be neutralized before proceeding to Enumeration and Specific Organism analyses.
| Interfering Substance | Potential Neutralizing Agents/Methods |
| Glutaraldehyde, mercurials | Sodium hydrogen sulfite (Sodium bisulfite) |
| Phenolics, alcohol, aldehydes, sorbate | Dilution |
| Aldehydes | Glycine |
| Quaternary ammonium compounds (QACs), parahydroxybenzoates (parabens), bisbiguanides | Lecithin |
| QACs, iodine, parabens | Polysorbate |
| Mercurials | Thioglycollate |
| Mercurials, halogens, aldehydes | Thiosulfate |
| EDTA (edetate) | Mg ions, Ca ions |
Product classification dictates the choice of the particular microbial enumeration test and acceptance criteria used to determine microbial quality. Following a defined incubation period, estimated microbial bioburden is determined by quantification of colony-forming units (cfu).
There are 3 compendial methods for quantifying product microbial content:
As with Microbial Enumeration tests, screening for specified microorganisms requires a preliminary suitability analysis and, if required, inclusion of a neutralization agent prior to testing. Here, product samples are streaked onto selective agar plates to determine the presence or absence of certain undesirable microorganisms.
The following microorganisms are screened for over the course of this test:
With over 51 years of experience consumer product testing and regulatory compliance, CPT Labs is well-positioned to be an extension of your Quality Assurance team. With regard to Microbial Limits testing, our Microbiology Division offers expertise across multiple industries including pharmaceuticals, OTC drugs, consumer healthcare products, cosmetic and personal care products, specialty chemical, and medical device industries. Our seasoned professionals are well-versed in technical knowledge associated with the FDA, EPA, and international consumer product regulations. All testing is accurately and appropriately conducted according to compendial and validated standards. We aim to best suit our clients’ needs and strongly adhere to Good Laboratory Practices (GLP), GMP, and Good Clinical Practices (GCP) standards. Custom-tailored testing programs and flexible turn-around times are available. Contact us at your earliest convenience.
Based on the individual needs of our clients, we offer a wide range of support across various departments. Since initial product testing can be fairly complex in terms of a high-quality, safe and trusted product, our clients typically explore the benefits of numerous departments and areas of expertise, including: